...
机译:肝切除与经转截管动脉化疗栓塞治疗肝细胞癌和肝静脉或下腔静脉肿瘤血栓:倾向评分匹配分析
Department of Hepatic Surgery VI Eastern Hepatobiliary Surgery HospitalSecond Military Medical;
Department of Hepatic Surgery VI Eastern Hepatobiliary Surgery HospitalSecond Military Medical;
Department of Hepatic Surgery VI Eastern Hepatobiliary Surgery HospitalSecond Military Medical;
Department of Hepatic Surgery VI Eastern Hepatobiliary Surgery HospitalSecond Military Medical;
Department of Hepatic Surgery VI Eastern Hepatobiliary Surgery HospitalSecond Military Medical;
Department of Hepatic Surgery VI Eastern Hepatobiliary Surgery HospitalSecond Military Medical;
Department of Hepatic Surgery VI Eastern Hepatobiliary Surgery HospitalSecond Military Medical;
Department of Hepatic Surgery VI Eastern Hepatobiliary Surgery HospitalSecond Military Medical;
Department of Hepatic Surgery VI Eastern Hepatobiliary Surgery HospitalSecond Military Medical;
Department of Hepatic Surgery VI Eastern Hepatobiliary Surgery HospitalSecond Military Medical;
hepatic vein tumor thrombus; hepatocellular carcinoma; liver resection; TACE;
机译:肝切除与经转截管动脉化疗栓塞治疗肝细胞癌和肝静脉或下腔静脉肿瘤血栓:倾向评分匹配分析
机译:肝切除与经导管动脉化疗栓塞治疗门静脉瘤血栓合并肝细胞癌
机译:经导管静脉化学栓塞治疗侵袭肝静脉或下腔静脉的肝细胞癌的结果
机译:倍半萜类药物可作为肝细胞癌(HCC)的潜在治疗方法:在大鼠HCC肿瘤模型中,通过经动脉化学栓塞术施用的小白菊内酯的临床前评估。
机译:经动脉化学栓塞(TACE)联合索拉非尼治疗门静脉瘤血栓形成的HBV背景性肝细胞癌:倾向评分匹配研究
机译:肝切除与强度调制的放射治疗治疗肝静脉肿瘤血栓的肝细胞癌:倾向评分匹配分析